Effect of geniposide on serum IL-1β and TNF-α of rheumatoid arthritis rats
Wenjun Sun
Abstract
Wenjun Sun
Abstract
Objective: To study the effect of geniposide on serum IL-1β and TNF-αlevels of rheumatoid arthritis rats, as well as the mechanism of this drug. Method: To establish an experimental rat model of type Ⅱ collagen-induced arthritic (CIA). The inhibitory effects on paw edema were observed, and serum IL-1β and TNF-α levels were determined in experimental rats. Result: Compared with the model, geniposide delayed the starting time of right paw edema significantly, and the levels of serum IL-1β and TNF-α were significantly decreased by geniposide at high dose or medium dose(P0.01). Conclusion: Geniposide can lower serum IL-1β and TNF-α levels in rheuma-toid arthritis rats. The effect may be close related to inhibitory development of rheumatoid arthritis by the agent.
OpenAlex reports 2 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective: To study the effect of geniposide on serum IL-1β and TNF-αlevels of rheumatoid arthritis rats, as well as the mechanism of this drug. Method: To establish an experimental rat model of type Ⅱ collagen-induced arthritic (CIA). The inhibitory effects on paw edema were observed, and serum IL-1β and TNF-α levels were determined in experimental rats. Result: Compared with the model, geniposide delayed the starting time of right paw edema significantly, and the levels of serum IL-1β and TNF-α were significantly decreased by geniposide at high dose or medium dose(P0.01). Conclusion: Geniposide can lower serum IL-1β and TNF-α levels in rheuma-toid arthritis rats. The effect may be close related to inhibitory development of rheumatoid arthritis by the agent.
Key concepts: Rheumatoid arthritis, Medicine, Tumor necrosis factor alpha, Arthritis, Pharmacology, Edema, Internal medicine, Endocrinology